Cassie Jung, Chief Operating Officer at Aquestive Therapeutics, Inc. (AQST), sold 62,180 shares at $5.00 ($311K) on 2025-09-04, disclosed to the SEC on 2025-09-08.
Scheduled sale ($311k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AQST | SELL | 2024-11-27 | $214 | — | Filing → |